Corporate Profile
Our Vision, Mission and
Values
Our Investment Criteria
Board of Directors
Advisory Panel
Investment Professionals
Corporate Professionals
Biomedical Sciences
Clean Technology
Digital Media
Other Key Industries
26 Jan 2010
CWT Announces EDBI as the New Investor
Other Key Industries
CWT Limited, a leading Singapore headquartered integrated logistics service provider with global operations, today announced the subscription of 16 million new ordinary shares by strategic investor, EDB Investments Pte Ltd (“EDBI”).
06 Jan 2010
Innovalight Raises an Additional $18 Million to Expand Silicon Ink Manufacturing
Clean Technology
Innovalight, Inc., a privately-held firm selling silicon ink-based high efficiency solar cell materials and technology, today announced that the company has raised $18 million in additional capital.This series D financing was led by EDB Investments (EDBI) of Singapore.
02 Dec 2009
S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety & Tolerability in P1 Studies.
Biomedical Sciences
S*BIO Novel Oral JAK2 inhibitor SB1518 demonstrates safety & tolerability in P1 studies for the treatment of Myeloproliferative & other hematological disorders
01 Dec 2009
Forma Therapeutics raises $25.5M Series B
Biomedical Sciences
Forma Therapeutics raises $25M Series B
27 Nov 2009
Eye on Mandarin Market
Digital Media
Xinya Media, a new home-grown cable content provider, has lined up plans to create programmes to reach 12 billion people.
26 Nov 2009
Xinya Media Completed Its Latest Round of Financing
Digital Media
Xinya Media (Xinya) today announced that EDB Investments (EDBI) has taken a stake in Xinya. Including the investments from Gobi Partners and Cheng’s Film, Xinya has successfully raised a total amount of US$9 million in this round. The new funds will aid the growth plan of Xinya and expand its market reach in Asia Pacific.
04 Nov 2009
MerLion Pharmaceuticals Pte Ltd receives IND Approval from the FDA for Finafloxacin.
Biomedical Sciences
MerLion Pharmaceuticals Pte Ltd receives IND approval from the FDA for Finafloxacin.
28 Oct 2009
ScanScout Completes $8.5 Million Series B Funding Round
Digital Media
ScanScout ( http://www.scanscout.com ) today announced that Singapore based EDB Investments (EDBI) has made an investment in ScanScout to close the in-stream video ad provider’s series B round at $8.5 million.
06 Oct 2009
Inviragen Merges with SingVax & Completes $15 million Series A Financing
Biomedical Sciences
Inviragen merges with SingVax and completes $15 million Series A financing.
25 Aug 2009
Fluidigm:250M Microfluidic Valves Manufactured
Biomedical Sciences
Fluidigm today announced that its Singapore biochip factory has manufactured and shipped more than 250M microscopic NanoFlex valves.
18 Aug 2009
Adamas Pharmaceuticals Raises $40M in Series D Financing
Biomedical Sciences
Adamas Pharmaceuticals has closed a $40M Series D round of funding led by Aeris Capital AG
18 Aug 2009
Adamas Pharmaceuticals signs crada with U.S Navy.
Biomedical Sciences
Adamas Pharmaceuticals signs crada with U.S Navy to conduct preclinical studies of triple-combination antiviral drug therapy for influenza A.
17 Jul 2009
Conformis raised US$50M from global investors
Biomedical Sciences
Conformis, a unique Medtech company with a customized approach to knee surgery replacement announced it has raised more than $50M from global investors.....
18 Mar 2009
S*BIO Pte Ltd
Biomedical Sciences
S*BIO Receives BioSingapore’s 2009 Award for the Most Successful Bio-Partnership in Asia
15 Mar 2009
Forma Therapeutics
Biomedical Sciences
FORMA Therapeutics and Experimental Therapeutics Centre of Singapore Collaborate to Develop Therapeutics Against a Broad Range of Novel Targets
06 Mar 2009
S*BIO Pte Ltd
Biomedical Sciences
S*BIO Receives BioSpectrum Editor's Choic, Emerging BioScience Company of Singapore Award
21 Jan 2009
S*BIO Pte Ltd
Biomedical Sciences
S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
06 Jan 2009
S*BIO Pte Ltd
Biomedical Sciences
S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the North American & European Markets
06 Jan 2009
Forma Therapeutics
Biomedical Sciences
Forma Therapeutics Debuts with 25 Million in Funding - Will Focus on Difficult Cancer Targets
31 Dec 2008
Singapore Medical News
Biomedical Sciences
EDB reports an outstanding year of growth and quality investments in 2007
13 Nov 2008
Inotek Pharmaceuticals Corporation
Biomedical Sciences
Patents Issue for Inotek Pharmaceuticals' Lead Clinical Candidates in Glaucoma and Contrast-Induced Nephropathy
20 Oct 2008
S*BIO Pte Ltd
Biomedical Sciences
S*BIO Completes US$26 Million Equity Financing
18 Sep 2008
S*BIO Pte Ltd
Biomedical Sciences
S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
09 Sep 2008
ES Cell International Pte Ltd
Biomedical Sciences
ES Cell International Announces Partnership with Large Pharma for assessment of GMP-Grade Stem Cell Lines
09 Sep 2008
Dx Assays Pte Ltd
Biomedical Sciences
Singapore's first Commercial Developer of Molecular Diagnostic Assays commences operations
09 Sep 2008
ES Cell International Pte Ltd
Biomedical Sciences
Human Stem Cell help mice in MS Research
22 Jul 2008
Merlion Pharmaceuticals Pte Ltd
Biomedical Sciences
BRAIN expands its BioArchive by the acquisition of genetic resources for White Biotech screening from MerLion Pharmaceuticals GmbH
21 May 2008
U3 Pharma AG
Biomedical Sciences
Daiichi Sankyo Co Ltd. to buy U3 Pharma for US$234M (150M Euros)
28 Mar 2008
Alexza Pharmaceuticals, Inc.
Biomedical Sciences
Bio*One takes US$10m stake in Nasdaq firm
06 Dec 2007
Merlion Pharmaceuticals Pte Ltd
Biomedical Sciences
MerLion MerLion Pharmaceuticals Wins Prestigious Pharmaceutical Industry Scrip Award
03 Dec 2007
Dx Assays Pte Ltd
Biomedical Sciences
QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products
[
Top |
Home
]
Contact Us
| © 2008 EDBI. All rights reserved.